Good morning.
Futures flat after quarter-end window dressing. Asia mixed — Nikkei off on yen at 40-year lows, Hang Seng drifting. JOLTS beat (7.594M vs 7.296M) but consumer confidence missed — macro still a tug-of-war.
No major AH prints, but the tape is screaming semis. SOX +83% in Q2 — best quarter ever, 20 points above dot-com peak. SNDK +857% YTD, MU +303%, INTC +278%. The rotation out of Mag7 into chips is the only narrative that matters. MSFT dropped 18.4% in June — its worst month since 2000. Over $2T evaporated from Magnificent 7.
Three themes framing today:
1. Rotation accelerates. Semis swallowed Mag7's lost market cap. The question: can the SOX hold after historic parabolic move? Window dressing helped — real demand from HBM, packaging, and inference keeps the bid.
2. AI inference disruption is real. Etched exits stealth with $800M raised, $1B+ customer contracts, working A0 silicon on TSMC N4P. They claim 80%+ sustained FLOPs utilization vs GPU 20-50%. Negative for NVDA's inference monopoly narrative. Positive for AVGO, MRVL, TSMC — and HBM demand (cluster-scale memory). The inference chip TAM just got validated at >$50B.
3. Memory supercycle isn't slowing. MU management meeting highlights roadmap traction, SOCAMM/LP5/6 progress. SK Hynix files for US listing ($SKHY) — HBM pure-play access. SNDK up 857% YTD, $DRAM ETF hit $25B AUM fastest ever. Elasticity from cheaper inference only adds to HBM consumption.
Also watch: AMZN Bedrock on pace to $25-30B ARR with >50% margins. Custom silicon (Trainium) pays off. BE +8% on $25B Brookfield partnership for AI fuel cells.
We'll hit up MU and SNDK first, then get to NVDA and AVGO.
Verdict: DLR is buying its way into hyperscale clarity. The $3.5B Blackstone JV buyout (64% stake, $7.8B gross) is the right move — anchored tenant credit, long duration, and a 6.5% going-in cap that’s accretive by 2027. But the market is pricing this perfectly. DLR +25% YTD. Consensus PT ~$220-235. At $68B market cap, upside is modulated. The bull case is about securing irreplaceable NOVA power; the bear case is about balance sheet stretch and execution risk on the other $1.5B+ of land/capex.
DLR is buying out Blackstone’s interest in three fully-leased in-development hyperscale data centers in Northern Virginia — 288MW total, split 2 in Manassas (96MW each) and 1 in Sterling (96MW). Price tag: $3.5B ($1.2B cash + $2.3B stock) plus assumed debt and ~$1.4B future capex. Gross asset value: $7.8B. That’s roughly $27M/MW — a firm print for NOVA pre-stabilized assets.
Tenant quality? Three distinct investment-grade hyperscalers (blended Aa3/AA-), locked into 15-year leases with 3.6% annual escalators. Stabilization in 1H27 (two facilities) and 1H28 (one). DLR expects the deal to be leverage-neutral and Core FFO-accretive by 2027. Analysts get it.
“Acquiring fully-leased, hyperscale assets from a JV partner at a 6.5% stabilized cap rate with 15-year IG tenants and escalators is about as clean a capital deployment as you’ll see in this space.” — BMO / Stifel / Bernstein consensus (paraphrased for tone)
Separately, DLR has been busy: $475M for 1,440 acres in Kansas City (600MW secured power by 2028), $650M for incremental 16% of Teraco (now 77% owned), and $485M for Columbia Capital (digital infra fund). This is a land-and-power grab, layered on top of the NOVA deal.
Bull (Bernstein, Stifel, BMO): DLR is securing irreplaceable NOVA capacity with zero lease-up risk. The 6.5% cap is attractive relative to where DLR trades (~4.5% implied cap on NAV). The Kansas City landbank opens a new market with 2GW potential. Accretion in 2027-2028 is real. Price targets $220-235 = ~15% upside.
Bear (the price action): The stock has rallied 25% in six months. At $68B, the market has already priced in this deal and more. Dilution from the $2.3B equity issuance (Blackstone selling at $185/share) is a headwind. The 6.5% cap doesn’t look great if hyperscaler demand softens or power constraints delay stabilization. Also, DLR’s other acquisition spree adds execution complexity — $1.5B across three separate deals in 60 days.
DLR is doing what it should do — using its public market currency to buy irreplaceable assets from a financial sponsor that wants liquidity. The stock’s run reflects that. Not sure there’s alpha left in the next 12 months unless we get a macro tailwind (lower rates / AI demand acceleration). But the quality of the earnings stream just got better. PMs should own it for the carry, not for a home run.
Verdict: SNDK's contract structure is the real story here — not the 4,300% rally. Bernstein just took their PT to $3,000 from $1,700 (stock at $2,050) and the bull case goes to $3,250. The key? Long-term agreements with upfront financial commitments that create a floor under earnings even in a crash scenario. This isn't your father's take-or-pay.
Bernstein's analysis shows those contracts lock in a floor price of $0.29/GB — inline with Q2 2026 ASPs — covering 60% of volumes. They modeled a 72% peak-to-trough ASP decline (worse than 2010) and still get FY30 EPS of $214. That's why the stock trades at 68x P/E but a PEG of 0.18. The market is pricing in the upside without fully discounting the downside protection.
"The ratio of financial guarantees to remaining contract value is dynamic and increases over time as revenue gets recognized, strengthening protection in the latter part of contracts."
Base case FY27/FY28 EPS now $243/$272; bull case $350/$400. The consensus is catching up — PTs range from $1,800 (Cantor, old) to $3,250 (Susquehanna), with Barclays upgrading to Overweight at $2,300. S&P also bumped to BB+ (debt repaid, net cash). Data center rev +191% YoY, every segment >100% ASP growth. The bear case is cyclical peak risk, but Bernstein's work suggests the trough is substantially higher than anyone assumed. Worth chewing on for PMs who hate owning NAND at 68x earnings.
Raymond James throws shade at the AI software multiple washout. Initiates Strong Buy with a $10 PT (30% upside from $7.65). Analyst Mark Cash sees a broken risk/reward — stock down 35% over six months, valuation “overly punitive” after AI software compression and execution fears. Thesis rests on organic growth reacceleration, improving retention/expansion, and forward visibility that makes 2026 conservatism look stale.
The Q1 print was mixed — EPS miss (-$0.02 vs -$0.01) but revenue beat ($93.5M vs $92.9M). More importantly, FY26 revenue guidance raised to $400M midpoint (16.5% YoY, up from 14.8%) thanks to the Statsig/OpenAI partnership. Piper Sandler also standing pat with Overweight/$9.
“Downside scenarios would imply a broken software outcome… such an outcome appears unlikely if Amplitude’s behavioral data foundation and action-oriented platform remain relevant in the agentic era.”
Bottom line: This is a classic “thrown out with the bathwater” name. If the behavioral data moat holds in an agentic world, the current multiple is a gift. 2026 still has landmines (restructuring, AI monetization), but the r/r is skewed favorably if they keep executing. Not a position size hitter, but a decent high-conviction small cap for the PMs willing to look past the AI selloff.
BERNSTEIN OUTPERFORM, $60 PT – the stock at $30.14 (nearly 50% upside). The call: tactical buy into H2. They see the 600bps growth deceleration as a transient clusterfuck – not a structural problem. Price hikes rolling off (200bps headwind), DOGE seat compression (100bps), and weak post-COVID 3-year renewals dragging (300-400bps) all fade by Q4 and flip into tailwinds into FY27. The narrative shift from "decelerating" to "re-accelerating" is the real prize.
“The firm described the stock as a tactical buy into the second half of the year.”
Verdict: Craig-Hallum starts with a Buy and $36 PT, calling the current 7.5x FY27 P/E absurd for a biz with $450M+ in NOLs and three distinct acceleration levers. The stock is down and dirty after the Q3 miss (EPS $0.06 vs $0.48 est), but that was largely a function of $9M in revenue slippage from ME conflict and Tier 1 pushouts — not structural. Gross margin cratered to 29.4% from 35.8% on the volume drop, so the leverage story is intact.
The firm sees three catalysts: (1) MDU fixed wireless, with initial orders larger than Aviat's biggest historical project, (2) BEAD kicking in 2H CY26, potentially adding $100M in revenue over multiple years, and (3) Nokia's microwave exit creating installed-base churn + Europe getting serious about Huawei bans. That's a clean setup for share gains.
"At 7.5x our FY27 estimate, the market is pricing in a permanently impaired business — we think the delay-driven miss is transient and the catalyst stack is as strong as we've seen in this space." — Craig-Hallum
Other noise: Northland upgraded to Outperform on a $25-30M fixed-wireless order (likely Verizon), and the company expanded its all-indoor microwave platform into a $250M+ TAM. NOLs ($450M+) shield future taxable income — not nothing for a sub-$300M market cap. The r/r here is asymmetric if BEAD or Nokia's exit materializes on schedule.
BUY WTS. Barclays just slapped an Overweight on this water tech name with a $414 PT (from $317, ~15% upside from here). Thesis is straightforward: WTS is the best plumbing/drainage/cooling play in the data center capex cycle. They're bumping 2026-2028 revenue estimates +2%, projecting 7% organic growth in 2027-2028. EBITDA estimates are 4% above consensus for those years. Stock already up 47% over the past year, but the data center content story is still underappreciated.
"Watts Water is best positioned among its Waste & Water Tech coverage group to benefit from the data center capital expenditure cycle..."
Catalysts on deck: raised 2026 guidance with Q2 results (August?), incremental disclosure on content per gigawatt, and new product rollouts. Residential housing exposure (~30% of 2025 revs) is a free option — Barclays isn't modeling a recovery, but if housing turns, that's straight upside. Q1 EPS beat by 13% ($3.04 vs $2.68) so momentum is real. Risk: valuation at ~30x forward earnings, but rate of change on data center demand is accelerating. R/R works here.
DA Davidson pulls the “Excess Cash” tag. Reiterates Neutral / $12 PT. Stock still cheap (7.8x P/E, 9% FCF yield, 3.6% div yield) but the catalyst that got them on STAMPEDE is done: cash dropped from $92.9M to $49.8M after $18.5M in buybacks, $14.3M in dividends, and $34.6M for Build38 acquisition. No more dutch auction or special dividend in the near term.
“The firm no longer sees another dutch auction or one-time special dividend as likely given the lower cash balance.”
Additional M&A still on the table as management hunts for organic growth reacceleration, but deal size and scope are smaller now. The Q1 beat (EPS $0.45 vs $0.35, rev $65.9M vs $61.21M) shows underlying ops are fine — just not enough to move the needle on their own. New partnership and marketing hires signal they’re trying. R/R is okay for a value trap, but the narrative pivot has already happened. No rush to own it here.
Bernstein staying Outperform at $295 – and actually making a case the worst is behind. Stock at $82 (down 63% from high) but the bear camp is losing steam. Bernstein sees Data Center accounting headwinds troughing by Q1 CY27, with visibility improving through H2 this year. Three dominant bear narratives – seat compression, DIY replacement risk, next revenue stream – all moderating. Cloud growth remains healthy (24.7% LTM, 84.8% gross margin) and AI disruption fears are fading on execution.
"Concerns about seat compression appear less believable based on hiring plans and product team narratives... Worries about do-it-yourself or competitive replacement are coming up less as investors appreciate the difficulty of achieving a positive return on investment given Atlassian’s inexpensive pricing and the operational challenge to replace it."
Not a screaming buy yet, but the rate of change in sentiment is positive. Risk/reward improving as the model clean-up plays out.
Market hates this deal. ON down 31% in a week after announcing the $7B all-stock acquisition of Synaptics. Strategic logic is there – pairing power/sensing with edge-AI compute and connectivity to target a $243B TAM by 2030 – but the market is pricing in execution risk and complexity. UBS stays Neutral at $95, noting the Q2 guidance reiteration is "somewhat surprising" given strength in analog.
UBS analyst Timothy Arcuri: "This was somewhat surprising given the strength seen across the broader analog space."
Street split down the middle. Needham goes to $130 with a Buy, Mizuho Outperform at $150 – they see the AI TAM expansion and $200M in SG&A synergies. TD Cowen downgraded to Hold, flagging "added complexity to the earnings model." Stifel and Cantor swing Neutral at $107/$100. The 1.35x share ratio (19% premium) and 18-month EPS accretion timeline give a long fuse. For PMs: this is a show-me story on execution and synergy realization, not a near-term catalyst.
HSBC cuts FTNT to Reduce (from Hold) — the rare downgrade in a sea of Buys. Raises PT to $102 from $98, but that’s still 13% below the close. Thesis: 46.1x 2026 P/E is in line with the cyber peer median, yet FTNT only delivers an 11.6% EPS CAGR. Risk/reward is unattractive at current levels. A fresh large-scale device security event could decelerate product and billings momentum from Q1’s beat. HSBC’s 31x target multiple is a steep discount to sector median of 46x, but they argue that’s warranted given the growth profile. (Only 11.6% CAGR vs. a 9.44 PEG? That math hurts.)
“The risk-reward looks unattractive at current valuation. A fresh large-scale device security event raises the odds that products and billings momentum will decelerate from the first quarter as customers potentially scramble to understand the breach.”
Counter-narrative: Q1 was a monster — revenue +6.7% vs consensus, billings +14.6% on AI infrastructure security spend. TD Cowen just went to $160 (Buy). Cantor sits at $110 (Neutral). The bull case is that AI-inferencing edge security is FTNT’s next leg. The bear case is that the multiple already prices in perfection, and the “security event overhang” is real. HSBC is the first to pull the ripcord. Worth watching if the street follows.
Verdict: Bernstein goes to bat on valuation — thinks NOW is the cheapest mid/large cap software on an FCF ex-SBC basis vs. 3yr growth. DOWN 52% FROM A YEAR AGO TO $102, so the setup is entirely about rate of change: comps get easier in H2, federal headwinds (DOGE, shutdowns) fade, and Now Assist pilots convert to broader deployments with measurable ROI. Bernstein sees mid-tens-of-millions of consumption revenue upside in 2H alone.
"ServiceNow is the least expensive mid/large cap software stock when price to next-twelve-month free cash flow minus stock-based compensation is compared versus three-year growth CAGR."
Not much fresh here beyond the valuation hook and the "lap easier comps" narrative — but that’s exactly the kind of low-expectation entry the buy-side loves when AI adoption is still accelerating. Fed normalization is a real wildcard; if it holds, NOW could squeeze hard from these levels.
BofA won’t budge on Buy / $310 PT — the call here is AWS pricing power, not retail. Last Friday AMZN announced a 20% hike on EC2 Capacity Blocks for ML (effective July 1), following a 15% bump in January. BofA’s expert call from June 11 showed effective prices paid by customers are already 22% above 2022 troughs. They see a 1-2pp tailwind to 2H AWS growth from these increases alone.
The bigger story is the ramp of committed workloads. OpenAI’s $38B commitment and Anthropic’s $100B commitment are both starting to show up in revenue — BofA notes Anthropic’s QoQ ARR and revenue growth is “notable,” with most capacity supplied by AWS. That’s the real accelerator, not just the price levers.
“The most recent price increase reflects a small subset of reserved AWS workloads. Other drivers of AWS revenue acceleration include the addition of OpenAI models on Bedrock and ramp of capacity for the $38 billion OpenAI commitment on AWS.”
Prime Day shifted to June this year — Adobe projecting $26.3B in online sales (+9% YoY). BofA estimates 1P GMV of $11.6B (+4.5%) and 3P of $10B (+5.0%). Solid but not a needle-mover for the thesis. This is an AWS story with a retail kicker. At 28.84x P/E and a PEG of 0.79, the r/r still works if AWS re-acceleration plays out.
UPGRADE FROM THE FOXHOLE. JPMorgan finally throws in the towel on their Underweight call, moving QLYS to Neutral with a new $139 PT ($87 prior). The thesis: vulnerability management is seeing real re-acceleration, and Qualys’ 200M+ agent footprint gives them a seat at the table. But this isn’t an all-clear — the price target reflects the view they still capture less of that tailwind than Tenable until ETM/CSAM bookings mix shifts (still just 11% of LTM bookings, up only 3pp in two years). VMDR still 50% of mix.
“The December 2027 price target reflects the view that Qualys captures less of the vulnerability tailwind than Tenable until bookings mix shifts and a long-term financial framework is disclosed.”
The margin profile is legit — 47% EBITDA, 57% Rule of 40, 45% FCF — well above the peer median of 26%. That’s the backstop. But the forward narrative hinges on whether the Risk Operations Center (full sales focus for 2026) can actually move the mix needle. RBC also nudged PT to $90 (from $85) on solid momentum and ETM/QFlex demand. Scotiabank cut to $100 (from $135) on billings growth of just 8% in Q1 — suggesting the re-rate has limits without a step-change in new business velocity.
Bottom line: Structural margin floor, narrative ceiling. Upgrade removes downside tail risk, but you’re still waiting for the bookings inflect. Not a buy, not a short — just a "show me" hold until the mix story gets real.
BMO INITIATES OUTPERFORM WITH $453 TARGET — AND FRANKLY, THE STOCK'S 320% RUN OVER THE PAST YEAR MAKES THIS FEEL LATE TO THE PARTY. BUT THE THESIS HOLDS. MKSI owns what BMO calls "one of the broadest critical-subsystem franchises" in semi equipment, plus exposure to advanced PCB and packaging chemistry via the Atotech acquisition. The bet here is that AI and data center buildout extend the cycle — not just the WFE upturn, but materials intensity at the leading edge and in advanced packaging.
"MKS Instruments offers one of the broadest critical-subsystem franchises in semiconductor wafer fabrication equipment... a levered beneficiary of dual AI and data center build-out drivers."
The Mizuho raise to $400 (from $390, Outperform) adds a second voice in the same key — they see WFE hitting $153B in 2026 and $190B in 2027 on AI logic and memory fab expansion. Q1 was a beat ($2.30 vs $2.04 est, revs $1.08B vs $1.05B). $25M China facility expansion double capacity by 2027. The stock already prices a lot of this in (26x forward? rough math) — but if cycle duration is truly extending, decent set-up for continued multiple expansion. Not a re-rating story; a compounding story in a high-beta semi cap name.
Truist cuts PT to $165 from $180, keeps Buy. Stock's been gutted — DOWN 31% IN SIX MONTHS — on AI sector valuation rot and a haircut to long-term growth expectations. Firm trimmed revenue CAGR assumption to 9.5% from 11%, finally throwing in the towel on being ahead of consensus. But here's the rub: they still see solid Q4 and double-digit recurring revenue growth. The 69% gross margin is a reminder this isn't a broken business.
"We anticipate a pattern of beat-and-raise dynamics as fiscal year 2027 progresses, with estimates potentially walking up based on solid business execution."
The cut is a function of multiple compression and slower top-line glide path, not a deteriorating ops story. If the macro cooperates and AI fears ebb, the setup for positive revisions is real — but for now, patience required.
Acquisition cap removes upside. William Blair throws in the towel at $54. The $8B takeover by Rocket Lab (RKLB) at $54/share in a mixed cash/stock deal leaves almost no juice for holders — stock sits at $53.05. DiPalma downgrades to Market Perform, noting the end of a remarkable 13-year coverage run. The 156% six-month run-up already priced in the premium.
“Assuming this deal goes through, it marks the end of a remarkable journey for Iridium, a company that we have covered since 2012.” — Louie DiPalma, William Blair
Upside? Not really. $54 is the ceiling minus deal risk (which is low, given spectrum strategic value). New Street started at Neutral/$40 pre-deal, so that’s the floor if anything breaks. No incremental catalyst — this is a spread-play now, not a fundamental call. PMs should treat it as a soft close-out.
Verdict: The quantum narrative finally has a liquid public name. Quantinuum is the consensus pick for lowest-risk quantum exposure, and the street is piling in with near-uniform $90-100 PTs. Craig-Hallum leads the charge with a $100 target, calling it the "lowest risk way to invest in quantum computing in the public markets." The market cap sits at $19.75B (QNT +25% over six months), but the real story is the balance sheet — CURRENT RATIO OF 11X, $2.6B cash per Evercore — giving them a decade-long runway to breakeven. Every analyst that's touched this has said buy or outperform. Not a single hold or sell in the batch.
"Quantinuum represents the lowest risk way to invest in quantum computing in the public markets today." — Craig-Hallum
The trade: $71.94 now, $100 consensus PT implies ~39% upside. But this is a long-duration bet — no near-term revenue catalyst, just roadmap execution and fault-tolerant milestones (Mizuho explicitly cites the fault-tolerant tech roadmap). The risk is that quantum timelines slip again, but the balance sheet buys time. PMs looking for a clean way to play the quantum cycle without the binary risk of Rigetti/IonQ should just buy QNT and ignore the noise.
Verdict: Goldman (Buy, $30 PT) is doubling down on Figma Make as the next catalyst vector, but the stock is a corpse down 83% from highs. GS came out of Config bullish on the AI product cycle and seat expansion, but the brutal YTD (-50%) tells you the market isn’t buying the narrative yet — margin pressure and competitive noise (Anthropic, Findell agitating for cuts) are real headwinds.
Figma is positioning as the "control layer" for modern product dev, with non-designer prototyping happening outside but workflows converging back into Figma for iteration and handoff. Make’s functionality has improved meaningfully since launch, and seat counts are stable to growing. The bull case hinges on AI monetization via credit consumption, which is early but tracking.
"The most likely path for the stock is up near term given new products and Make monetization, though it may be challenging for the stock to move sustainably higher in the face of ongoing gross margin pressure and evolving competition."
The bear case writes itself: CEO just sold $4.4mm, Findell is publicly calling for cost cuts and governance review, and margins are under structural pressure despite 80% gross margins. The AI story buys time, not re-rating — not yet.
TD Cowen throwing down a bullish bat signal on deliveries. They’re sticking with Buy and $490 target, and the kicker is their Q2 delivery estimate of 418k vs consensus ~406k. That’s a ~3% beat baked in, and they flag the June closeout effect — historically 48% of Q2 deliveries happen in the final month. Their model even points to potential mid-430k. A beat here could flip near-term sentiment after the stock’s 15.6% YTD slide (now $397, ~20% off the $499 high).
Barclays and Baird are also in the mix (Equalweight and Outperform respectively), but nobody’s cutting — the consensus is leaning higher on deliveries, and TD Cowen is the most explicit.
The thesis line worth stealing:
“Recent data and our predictive model suggest potential for deliveries in the mid-400,000 range.”
That’s the catalyst vector. If TSLA prints above 420k, the narrative around demand destruction starts to crack. If it prints inline or below, the stock has already de-risked some. Either way, June delivery data is the only game in town until the next growth story (Grok/X/energy) gets more tangible. PMs: watch the weekly delivery whisper numbers, not the stock price.
JPMorgan put the Focus List sticker on Tenable this morning, raising PT to $40 from $35 — that’s +19% from here. The call is pure rate-of-change: acceleration in vulnerability volumes + Hexa AI as a genuine upgrade hook for the 70% of customers still on legacy scanning. Stock already ripped 22.85% in the past week to $33.49, so some of this is in the price. But the math works: 30% of customers on Tenable One today, 40k+ base, ASP uplifts of 6-60%. The 2029 target model (HSD-LDD revenue growth, 28% op margin, 31% UFCF margin) gives JPM a clean 12.8x EV/FCF on CY27 estimates.
"Tenable is best positioned to benefit from an acceleration in vulnerability volumes that will likely lift exposure management vendors with vulnerability management exposure."
Hexa (powered by Claude, GA May 20) is the main vector — only available on Tenable One Foundation/Advanced, so it’s a forced upgrade path. Roughly two-thirds of the base sits on standalone VM. That’s the upsell fuel. Also worth noting: FedRAMP High authorization (for Department of War / intel agencies) expands TAM in fed, and the OpenAI partnership (GPT-5.5 integration) gives the narrative an AI tailwind.
The bear case: 21 analysts already revised estimates upward and the stock has repriced aggressively in a week. PTs from Needham ($30) and Stephens ($29) are well below current price — the range is wide. At 12.8x EV/FCF on 2027 numbers you need flawless execution on that platform migration. Margin expansion is baked in; any stumble on conversion rate or churn in the legacy base gets ugly. But JPM’s Focus List inclusion says they think the momentum is real, not a one-off.
Bottom line: High-conviction bull call on a structural catalyst (vulnerability volume + AI stickiness). Stock has run, but the forward hurdle is only $40 by Dec 2027 — that’s <5% annualized. If Hexa adoption ticks above the Street’s whisper line, multiples expand. Play it on pullbacks; don’t chase the green.
VERDICT: Wells Fargo lifts PT to $615 (from $505) on server CPU re-rate — they’re now modeling $16B in server CPU rev for 2026, $20.5B for ’27, $25B for ’28. That’s the core thesis, and it’s getting traction across the analyst community.
Cantor, UBS, Wolfe all chimed in this week with upgrades or raised PTs (Cantor to $700, UBS to $670). The common thread: EPYC Venice 2nm ramp is real—AMD says more customers are validating Venice than any prior generation. Data center GPU estimates unchanged at $15.6B/$40.6B/$63B for ’26-’28, so the CPU story is doing the heavy lifting on estimate revisions.
The stock at $539 (4% off 52-week high) trades 179x trailing — but Wells Fargo’s 33x forward P/E on 2028 EPS of $18.75 gets you to $615. Not sure we can read too much into current multiple compression risk when the rate of change in server CPU is still accelerating. Market cap now $850B, creeping toward $1T if GPU estimates ever catch up.
“AMD increased its server CPU total addressable market estimate to $120B by 2030 last quarter.” — company commentary, now reinforced by Wells Fargo’s model build
The funding question is now the stock’s overhang. Freedom Broker cut ORCL to $210 (from $230) but kept Buy — the analyst sees execution as necessary but not sufficient for a re-rate. The 4Q print showed cloud reacceleration, but the market is fixated on a $167B debt load and the 4.46x debt-to-equity that triggered a 10.5% weekly selloff (worst since dot-com). The bull case hinges on prepaid/customer-funded structures reducing external capital needs; the bear case says leverage is the new gravitational pull.
"The investment question has shifted from whether demand exists to whether Oracle can fund the build, convert the backlog into recognized revenue and cash, and defend its credit standing."
Re-rate only comes on conversion and funding proof points. Hard to get long until we see cash flow improve or a credible deleveraging plan.
William Blair pulls the ripcord. Downgraded to Market Perform from Outpatient (Outperform) this morning — not a shock given the 67% Y/Y decline, but the catalyst is real: visibility on a H2 reacceleration is evaporating. Middle East (4% of rev) worsening, Europe now showing spillover, and discretionary demand across IT services peers getting more cautious. Stock at $30.08, FCF yield of 25% screams value trap until growth proves in hand.
“Globant’s reaffirmed 2026 revenue guidance of $2.46B to $2.51B still embeds a meaningful reacceleration in the second half of the year, which the firm now views as increasingly difficult to underwrite given the low margin for error implied.”
AI Pods ARR target of $60-100M by year-end is the swing factor — if that doesn’t materialize, the H2 case breaks. Needham/Mizuho still bullish (PTs $50-59) but that’s a bet on large deal conversion against a worsening macro tape. PMs: this is a show-me story trading like a liquidation. Not stepping in until we see AI Pods actually accelerating, not just guided.
WF upgrades PT to $56 (from $55), stays Overweight — but this is a hold-the-line call, not a victory lap. Q3 bookings guide at $1.72-1.78B is 7-11% below consensus of $1.84B. That's the headline bogey. The bull case is Q2: they're above consensus on bookings (+12% YoY vs 10.9% street) and EBITDA ($240M vs $232M). Russia and Turkey DAU tailwinds (~124M vs 123M street) help, but engagement growth is decelerating into tough comps through October. Age-based rollout (June 16) hasn't hurt yet — but it's early.
"Engagement growth decelerated throughout 2Q against escalating YoY comparisons that persist through October — the June 16 age-based rollout has not appeared to impact engagement, though growth deceleration is likely to persist."
The bull case rests on Nov/Dec comps easing — full-year bookings growth of 8-12% still holds if the back half catches up. 51% of global DAUs were checked entering the quarter, so free cash flow conversion is the real swing factor. Right now, the stock sits at $54.34 — PT implies ~3% upside. Not screaming buy, but better r/r than the Q3 guide suggests if management executes through the summer lull.
BUY THE PULLBACK. Jefferies is pounding the table – reiterated Buy, $550 PT – citing CY2028 visibility that's actually getting better, not worse. Recent 25% drawdown from $495 peak has AVGO trading at ~10x forward EPS on their scenario analysis ($30-40/sh in CY2028). That's absurd for a company with this AI ASIC footprint.
The narrative engine here is dual: Google TPU roadmap locked through 2031 (TPU 8i ramps Q3 2026, potential >$500B cumulative revenue) plus the OpenAI Jalapeno XPU – developed in nine months, 50% lower cost and 40% lower power vs Blackwell. That's not just a product win; it's proof Broadcom can diversify beyond Google.
"Jalapeno represents an important step for Broadcom toward further customer diversification beyond Google." – Jefferies
Other analysts echo the thesis: CLSA cut PT to $600 but stays Outperform (roadmap clarity), JPM at $580 Overweight (TPU v9 2nm on track for 2028), Wolfe highlighting the Apollo/Blackstone XPV financing vehicle as a revenue accelerator by 2028. Consensus is not the question – it's whether the market reprices the multiple before the next catalyst (likely TPU 8i production). At $372, r/r is skewed massively to the upside.
The upgrade is a call on the sum-of-the-parts unlock, not the legacy cable business. Deutsche Bank goes to Buy but cuts PT to $32 from $34 — sounds like a downgrade if you don't read past the headline. It's not. The lower target is purely mechanical, swapping a market-based DCF for a SOTP model. The real signal: increased confidence in the separation thesis.
Current valuation is comically cheap. 4.78x P/E, PEG of 0.18. That's not a value trap if the split actually crystallizes value. The spin-off (Comcast Cable & Tech vs. NBCU/Theme Parks/Sky) is the catalyst, expected to close in ~12 months. Market clearly wants this — stock surged on the announcement, options activity spiked (127k contracts, heavy July 17 $25 calls).
"The price target reduction reflects the new valuation approach rather than a change in the company’s fundamental outlook." — Deutsche Bank
The bull case: Pure-play broadband with no media drag trades at a premium. The stub (NBCU) gets marked to reality. The bear case: Cable subscribers keep bleeding to fiber and fixed wireless, and theme parks roll over into a consumer slowdown. SOTP works both ways if the pieces are worth less than the sum.
Bottom line: This is a bet on strategic clarity and multiple expansion off a washed-out base. Not a story about operating momentum. PMs with 12-18 month horizons should look here. Those trading QoQ organic EBITDA miss the point.
NVDA — Bearish cross-currents are real. Etched's A0 silicon with 80%+ FLOPs utilization versus GPU's 20-50% is a credible inference threat — $800M raised and $1B+ contracts validate the TAM but pressure NVDA's pricing power. Rubin Ultra cancellation (3 months post-GTC) signals CoWoS scaling limits and roadmap wobble. CUDA moat is fraying: Triton/TileLang reduce dependency, AI agents compress migration costs. SemiAnalysis sees H2 DC revenue 20% above consensus but the rate of change on the competitive side is accelerating. The China domestic stack (Meituan's 1.6T model on 50K domestic chips) is a multi-year bear case, not near-term.
MU — DRAM pricing is on fire: UP 172% IN 2025, Q3 forecast revised to +15-20% QoQ from +8-13%. Structural shortage — customers signing 3-5 year LTAs with advance payments locks in elevated pricing through 2028. CXMT still trailing by generations, no near-term threat. The class-action price-fixing lawsuit is noise for now but adds regulatory tail risk. Charitable $250M to Trump Accounts is a nothingburger financially but shows community bridge-building alongside US fabs.
TSMC — The moat is widening by the quarter. CoWoS capacity targeting 2,000 KPcs in 2027 (from 1,100 KPcs in 2026) — aggressive defense against competing packaging. CoPoS panel-level could cut AI chip packaging costs 20-30% by 2028. Samsung sub-40% yields and Intel Feynman delay to 2029 mean TSMC's dominance is self-reinforcing. AI server + edge AI absorbing foundry capacity keeps trailing-node utilization high despite pricing pressure. Analysts raising PTs ahead of Q2 conference — Aletheia NT$3,500, UBS NT$3,400. The only risk: semi-cap valuations feeling full.
GOOGL — Cloud generative AI tailwind is real: Vertex doing well, TPU sales driving cloud revenue. Long-term ASIC deal with Broadcom to 2031 secures supply. TPU V10ax moving to Samsung foundry — diversification play, not a threat to margins. Gemini Omni Flash launched (video editing AI) — product line expansion. MS/GS see TPU contributing meaningfully to $300B target — ambitious but supported by AI. The bull case rests on cloud monetization accelerating, not ad recovery.
MSFT — Lost $2T in market cap in June — worst month since 2000. Rotation out of Mag7 is painful but fundamentals are strong. MSFT Foundry now includes Anthropic models — competitive catch-up vs AWS. Planning a 2GW data center in Pecos, TX with Chevron gas plant (first power 2028) — aggressive AI infra buildout. Azure Cobalt 200 VMs optimized for agentic AI — CPU-led workload validation helps pack more agent sandboxes per VM. AI partnerships in flux (Anthropic, OpenAI) but they're staying in the race.
INTC — Up 278% YTD — turnaround story already priced. 18A process has 30K WSPM capacity, but needs external customers. TSMC deliberately throttling capacity could create structural opening for Intel Foundry — higher conviction on capacity resolvers. Feynman delayed to 2029 — execution delays continue. Samsung's sub-40% yields hurt their foundry; Intel could benefit, but don't count on it near-term. The narrative is ahead of the fundamentals.
QCOM — Weak vs CPU peers despite the CPU tracker showing concentrated CPU revenue names — specific headwind. ByteDance finalizing in-house CPU, possibly with Qualcomm's help — potential design win but unconfirmed. Monoline risk is real: export control dynamics with China could cut both ways. ARM-based licensing opportunity if ByteDance CPU is ARM-based, but that's a low-conviction read.
ARM — ByteDance CPU likely ARM-based — licensing revenue opportunity. Low conviction but worth monitoring as China hyperscalers move up the stack into custom silicon. ARM's royalty model benefits from any non-x86 compute expansion.
ASML — Near all-time high with daily buybacks — strong momentum. Samsung to use High-NA EUV from 1.4nm node — confirms demand for future nodes. Semi-cap valuations looking full — risk of peak earnings. EUV bottleneck could delay fab buildout if demand slows. The marginal buyer is pricing in seamless expansion, but any hiccup in wafer starts hits ASML first.
AMAT — Advanced packaging revenue expected >$2B in 2026E, +50% YoY — step-function growth from HBM, panel-level packaging, hybrid bonding. DRAM complexity increases AMAT revenue per wafer: +10% from 6F² to 4F², another +15% moving to 3D DRAM — structural growth. Michael Burry shorting AMAT is a contrarian signal but could be early. China cost advantage limited to 10% due to high non-Chinese input share — supports US equipment dominance.
KLAC — WFE demand strong across the board — KLAC near highs, benefiting from angstrom-era wafer fabrication inspection. Semi-cap valuations looking full — risk of peak earnings. KLAC's inspection leadership means any node complexity increase drives content growth. The bear case is purely valuation-driven.
LRCX — Benefiting from WFE demand — strong Q2, near highs. Advanced equipment development for Samsung's 1.4nm confirms engagement in leading edge. China cost advantage max 10% — same structural support as AMAT/KLAC. LRCX is the most cyclical of the WFE trio, but the current cycle is driven by AI and memory, not PC/smartphone.
GLW — Up 192% YTD — re-rating underway. Repositioned as critical optical infrastructure supplier for AI — NVIDIA and Meta partnerships validate. Springboard strategy delivering margin expansion. Dominant fiber/photonics position. Risk in capital intensity and hyperscaler concentration — heavy reliance on few customers. But the narrative shift from commodity glass to AI-enabling optics is sticky.
BE — Surged 8% on expanded Brookfield partnership to $25B (5x increase). Solid fuel cells for rapidly deployable AI power — clean, rapidly deployable. AI infrastructure power demand narrative is real and Bloom is one of the few pure plays on the theme. Valuation is racing ahead but the contract growth is hard to ignore.
SMCI — Taiwan office raided in AI chip probe — allegedly routing Nvidia chips through Japan to China. Regulatory overhang is real and high-impact. Export control tensions flaring — new laws being considered in Taiwan could disrupt SMCI's business model. Stock could gap down on any negative development. Avoid until clarity.
META — Seen as 'Peter Lynch' opportunity with low expectations — contrarian long call. Open-sourced brain-to-text system with 78% word accuracy without surgery — potential mind-reading glasses (long-term, not near-term catalyst). Meta's AI spending is massive but the payoff in ad targeting and recommendation is underappreciated. The low expectations setup is intriguing but needs a catalyst.
PINS — Activist Jana Partners builds new position in 'Everpure' — likely PINS. Catalyst for shareholder value. Pinterest has been a fallen growth story; activist pressure could force operational improvements or a sale. Low conviction on the fundamental turn but the activist angle is real.
CSCO — Delayed enterprise networking refresh combined with AI data center interconnect drives localized cyclical recovery. Cisco's optical capabilities via Acacia acquisition position it well for data center interconnect demand as AI workloads push beyond single-site limits. Structural demand for DCI is real — CSCO is a laggard beneficiary but the risk/reward is improving.
CRM — Bearish: Salesforce led a $135M round into Chamathco, invalidating capital allocation discipline thesis. The market had given Marc Benioff credit for discipline; this deal reopens the "empire building" narrative. CRM already trading at a discount to peers — this doesn't help.